Skip to content
    Trademarks/Nicotinamide Mononucleotide/Uthever®
    Uthever® branded ingredient logo by EffePharm
    Trademarked IngredientNovel and Emerging Ingredients

    Uthever®

    A trademarked form of Nicotinamide Mononucleotide

    Parent Evidence
    50/100

    Manufacturer

    EffePharm

    Clinical Studies

    1

    Certifications

    2

    Purity

    Standard

    Last reviewed: 2024-05-05

    Technical Specifications

    Clinical Evidence

    0 trademark-specific studies · 1 parent (generic Nicotinamide Mononucleotide) study shown for context

    1
    Parent / generic Nicotinamide Mononucleotide evidence

    Multiple purity and stability studies

    Frequently Asked Questions

    What is Uthever?

    Uthever® is a trademarked form of Nicotinamide Mononucleotide manufactured by EffePharm.

    Who makes Uthever?

    Uthever is made by EffePharm.

    How much clinical evidence does Uthever have?

    SuppIndex lists 1 clinical study for Uthever and 2 certifications (Pharmaceutical grade, Self-GRAS). The parent ingredient Nicotinamide Mononucleotide has an overall evidence score of 50/100 (Limited).

    Parent Ingredient

    Nicotinamide Mononucleotide

    A nucleotide intermediate in the NAD+ salvage pathway that is converted to NAD+ by nicotinamide mononucleotide adenylyltransferase (NMNAT) enzymes, restoring cellular NAD+ pools critical for redox metabolism and epigenetic regulation.

    NAD+ restorationHealthy agingMetabolic healthEnergy metabolism

    View the parent ingredient page for full evidence review, dosage guidance, mechanism of action, and safety information.

    Manufacturer

    Uthever® branded ingredient logo by EffePharm

    EffePharm

    Website Contact

    Certifications (2)

    Pharmaceutical grade
    Self-GRAS

    Compare

    See how Uthever® compares to other forms or the generic version.

    Open Comparison